These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30410604)

  • 1. Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma.
    Su Q; Zhu EC; Qu YL; Wang DY; Qu WW; Zhang CG; Wu T; Gao ZH
    J Cancer; 2018; 9(21):3991-3999. PubMed ID: 30410604
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis.
    You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y
    Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis.
    Xin W; Fu Y; Chen L; Ding H; Feng T; Sun J; Qi Y; Hu Y; Fang Q; Fang L
    J Gastrointest Oncol; 2023 Apr; 14(2):719-732. PubMed ID: 37201049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression Characteristics of Tumor and Adjacent Non-Tumor Tissues of Pancreatic Ductal Adenocarcinoma (PDAC) In-Silico.
    Güven E
    Iran J Biotechnol; 2022 Jan; 20(1):e3092. PubMed ID: 35891953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the key genetic association between chronic pancreatitis and pancreatic ductal adenocarcinoma through integrated bioinformatics.
    Guo K; Zhao Y; Cao Y; Li Y; Yang M; Tian Y; Dai J; Song L; Ren S; Wang Z
    Front Genet; 2023; 14():1115660. PubMed ID: 37501719
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-Expression Network Analysis Identifies miRNA⁻mRNA Networks Potentially Regulating Milk Traits and Blood Metabolites.
    Ammah AA; Do DN; Bissonnette N; Gévry N; Ibeagha-Awemu EM
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis.
    Kong X; Du Y; Wang G; Gao J; Gong Y; Li L; Zhang Z; Zhu J; Jing Q; Qin Y; Li Z
    Dig Dis Sci; 2011 Feb; 56(2):602-9. PubMed ID: 20614181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Interaction Network of Hub miRNAs-Hub Genes, Being Involved in Idiopathic Pulmonary Fibers and Its Emerging Role in Non-small Cell Lung Cancer.
    Yu DH; Ruan XL; Huang JY; Liu XP; Ma HL; Chen C; Hu WD; Li S
    Front Genet; 2020; 11():302. PubMed ID: 32300359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
    Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
    BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.
    Hu X; Sun G; Shi Z; Ni H; Jiang S
    PeerJ; 2020; 8():e8505. PubMed ID: 32117620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma.
    Xu Q; Chen S; Hu Y; Huang W
    Cancer Cell Int; 2021 Oct; 21(1):582. PubMed ID: 34717651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.
    Zhou XG; Huang XL; Liang SY; Tang SM; Wu SK; Huang TT; Mo ZN; Wang QY
    Onco Targets Ther; 2018; 11():2815-2830. PubMed ID: 29844680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.
    Han SW; Pyun JM; Bice PJ; Bennett DA; Saykin AJ; Kim S; Park YH; Nho K
    Res Sq; 2023 Nov; ():. PubMed ID: 37961387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the
    Yonemori K; Seki N; Idichi T; Kurahara H; Osako Y; Koshizuka K; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
    Oncotarget; 2017 Sep; 8(41):70097-70115. PubMed ID: 29050264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes and MicroRNAs Associated With Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Analyses.
    Qiu X; Lin J; Liang B; Chen Y; Liu G; Zheng J
    Front Genet; 2021; 12():667406. PubMed ID: 33995494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
    Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.